Study identifies sex-biased mechanism of naive CD8+ T cell decline and lymph node contraction during aging

A Nature Aging study reveals that male-biased naive CD8+ T cell depletion and thymus involution impair cancer antigen recognition, which can be reversed therapeutically via thymus regeneration.

Researchers identified a sex-biased mechanism of immune aging where early male-biased depletion of naive CD8+ T cells, driven by accelerated antigen-agnostic differentiation into virtual memory cells, combines with thymic involution to restrict naive T cell replenishment.

This process causes accelerated lymph node contraction and limits the availability of local naive T cell clones in male models, resulting in compromised recognition of cancer antigens.

Therapeutic thymus regeneration achieved via androgen ablation repopulated lymph nodes with naive CD8+ T cells, restored cancer-specific T cell responses, and enhanced susceptibility to immune checkpoint blockade in male mice.

The findings provide a clear cellular basis for the sex-specific disparities observed in age-related immune decline and response to cancer immunotherapies.

By demonstrating that thymus regeneration can successfully repopulate peripheral lymph nodes and restore antigen recognition, the study establishes a strong preclinical proof-of-concept for therapeutics targeting immunosenescence.

The discovery highlights a commercial opportunity for therapies targeting thymus rejuvenation and immune restoration in aging populations.

Companies developing assets aimed at countering immune aging or enhancing immune function in older adults may see increased scientific interest in pathways that restore naive T-cell compartments.

Development of clinical-stage candidates targeting thymus regeneration or androgen modulation to confirm if these preclinical immune-rejuvenation effects translate to older human males.